Risk associated with a systematic search of extended-spectrum β-lactamase-producing Enterobacteriaceae

American Journal of Infection Control

Volumn 41, Issue 3, 2013, Pages 259-260

  Prinapori, Roberta ^a,b   Guinaud, Julie ^a   Khalil, Antoine ^a   Lecuyer, Herve ^a   Gendrel, Dominique ^a   Lortholary, Olivier ^a   Nassif, Xavier ^a   Viscoli, Claudio ^b   Zahar, Jean Ralph ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Bloodstream infection; Carbapenems; Deescalation

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; CHILD; CLINICAL ARTICLE; ENTEROBACTERIACEAE INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; HUMAN;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; CHILD; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS;

EID: 84875364040     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2012.03.035     Document Type: Article

References (10)

1. J.R. Zahar, O. Lortholary, C. Martin, G. Potel, P. Plesiat, and P. Nordmann Addressing the challenge of extended-spectrum β-lactamases Curr Opin Investig Drugs 10 2009 172 180
2. D. Marchaim, T. Gottesman, O. Schwartz, M. Korem, Y. Maor, and G. Rahav National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae-producing extended-spectrum β-lactamases Antimicrob Agents Chemother 54 2010 5099 5104
3. C. Backman, G. Taylor, A. Sales, and P.B. Marck An integrative review of infection prevention and control programs for multidrug-resistant organisms in acute care hospitals: a socio-ecological perspective Am J Infect Control 39 2011 368 378
4. A. Valverde, F. Grill, T.M. Coque, V. Pintado, F. Baquero, and R. Canton High rate of intestinal colonization with extended-spectrum β-lactamase- producing organisms in household contacts of infected community patients J Clin Microbiol 46 2008 2796 2799
5. J.R. Zahar, F. Lanternier, F. Mechai, F. Filley, F. Taieb, and E.L. Mainot Duration of colonisation by Enterobacteriaceae-producing extended-spectrum β-lactamase and risk factors for persistent faecal carriage J Hosp Infect 75 2010 76 78
6. T.C. Horan, M. Andrus, and M.A. Dudeck CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting Am J Infect Control 36 2008 309 332
7. P. Reddy, M. Malczynski, A. Obias, S. Reiner, N. Jin, and J. Huang Screening for extended-spectrum β-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia Clin Infect Dis 45 2007 846 852
8. M. Arnan, C. Gudiol, L. Calatayud, J. Linares, M.A. Dominguez, and M. Batlle Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies Eur J Clin Microbiol Infect Dis 30 2011 355 360
9. J.J. De Waele, M. Ravyts, P. Depuydt, S.I. Blot, J. Decruyenaere, and D. Vogelaers Deescalation after empirical meropenem treatment in the intensive care unit: fiction or reality? J Crit Care 25 2010 641 646
10. J. Rodriguez-Bano, M.D. Navarro, P. Retamar, E. Picon, and A. Pascual β-lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts Clin Infect Dis 54 2012 167 174